PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15846373-0	2005	tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.	tBID	0-4	carnitine palmitoyltransferase 1A	Homo sapiens	109-141	
15846373-3	2005	The measurement of beta-oxidation flux by labeled palmitate demonstrates that tBid inhibits beta-oxidation, thereby resulting in the accumulation of palmitoyl-coenzyme A (CoA) and depletion of acetyl-carnitine and acylcarnitines, which is pathognomonic for inhibition of carnitine palmitoyltransferase-1 (CPT-1).	tBID	78-82	carnitine palmitoyltransferase 1A	Homo sapiens	271-303	
15846373-3	2005	The measurement of beta-oxidation flux by labeled palmitate demonstrates that tBid inhibits beta-oxidation, thereby resulting in the accumulation of palmitoyl-coenzyme A (CoA) and depletion of acetyl-carnitine and acylcarnitines, which is pathognomonic for inhibition of carnitine palmitoyltransferase-1 (CPT-1).	tBID	78-82	carnitine palmitoyltransferase 1A	Homo sapiens	305-310	
15846373-4	2005	We also show that tBid decreases CPT-1 activity by a mechanism independent of both malonyl-CoA, the key inhibitory molecule of CPT-1, and Bak and/or Bax, but dependent on cardiolipin decrease.	tBID	18-22	carnitine palmitoyltransferase 1A	Homo sapiens	33-38	
15846373-4	2005	We also show that tBid decreases CPT-1 activity by a mechanism independent of both malonyl-CoA, the key inhibitory molecule of CPT-1, and Bak and/or Bax, but dependent on cardiolipin decrease.	tBID	18-22	carnitine palmitoyltransferase 1A	Homo sapiens	127-132	
15846373-5	2005	Overexpression of Bcl-2, which is able to interact with CPT-1, counteracts the effects exerted by tBid on beta-oxidation.	tBID	98-102	carnitine palmitoyltransferase 1A	Homo sapiens	56-61